www.alexion.com

Intended for US audiences only


Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Connect Perplexing Symptoms
With LOW Alkaline Phosphatase
The diagnosis may point to hypophosphatasia

www.alexion.com
www.hypophosphatasia.com/hcp

Virtual Drop In:

Thursday, November 3, 2022

  • 7:30 am - 8:00 am

  • 10:00AM – 10:30AM

  • 12:30PM – 1:30PM

  • 2:45 pm - 3:00 pm

Friday, November 4, 2022

  • 7:30 am - 8:00 am   

  • 10:00AM – 10:30AM

  • 12:30PM – 1:30PM


Access the virtual drop in

Contact Information:

Rebekah Jonjak
rebekah.jonjak@alexion.com
(608) 469-5613